IFP Advisors
FENC icon

IFP Advisors’s Fennec Pharmaceuticals FENC Stock Holding History

IFP Advisors’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$980 Hold
92
– – ﹤0.01% 4491
2026
Q2 		$989 Buy
92
+91
+9,100% +$743 ﹤0.01% 4497
2026
Q1 		$6 Buy
+1
New +$8 ﹤0.01% 4986
2025
Q2 		– Sell
-7
Closed -$43 – 4952
2025
Q1 		$43 Hold
7
– – ﹤0.01% 4048
2024
Q4 		$44 Buy
+7
New +$36 ﹤0.01% 4286

Other funds holding FENC

State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

IFP Advisors's FENC Position: Q3 2026 in Review

IFP Advisors held its Fennec Pharmaceuticals (FENC) position steady in Q3 2026 at 92 shares worth $980. The position accounts for ﹤0.01% of the portfolio, ranked #4491.

IFP Advisors first reported a position in FENC in Q4 2024 and has held it in 5 quarters since. The position peaked at $989 in Q2 2026. 9 funds tracked by Wall St. Rank hold FENC as of Q3 2026.

  • IFP Advisors held 92 shares of Fennec Pharmaceuticals worth $980 as of Q3 2026.
  • IFP Advisors left its Fennec Pharmaceuticals share count unchanged in Q3 2026.
  • Fennec Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4491 holding.
  • IFP Advisors first reported a position in Fennec Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • IFP Advisors's Fennec Pharmaceuticals position peaked at $989 in Q2 2026.
  • 9 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.